|
|
ChemGenex Pharmaceuticals Limited - Earning & Dividend Analysis Snapshot
This detailed Report provides an Earnings and Dividends history for ChemGenex Pharmaceuticals Limited. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.
ChemGenex Pharmaceuticals Limited. The Group's principal activity is operating as an integrated biopharmaceutical development company, focused on discovering and developing oncology drugs. Its product candidates include omacetaxine mepesuccinate (formerly known as Ceflatonin, homoharringtonine or HHT), which is and Quinamed (amonafide dihydrochloride). Operations are carried out in Australia and the United States of America.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|